ClinicalTrials.gg
Enrolling by invitationNCT07327333Updated Jan 8, 2026

The Effects of Contextual-Based Augmented Reality Facilitated Education in Promoting Oral Mucositis Care Among Nurses

An interventional study of Situational Augmented Reality-Assisted Teaching and Classroom Teaching in Nursing Education, sponsored by Mackay Memorial Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-01-08.

Sponsored by Mackay Memorial Hospital · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

In recent years, cancer has become one of the leading causes of death worldwide, with an increasing number of people being diagnosed with the disease. Current cancer treatments include surgery, chemotherapy (CT), radiotherapy (RT), concurrent chemoradiotherapy (CCRT), targeted therapy, immunotherapy, and hematopoietic stem cell transplantation (HSCT). While these treatments have improved survival rates for many patients, they often lead to adverse side effects, one of the most common being oral mucositis (OM). Oral mucositis in cancer patients differs from general types of oral ulcers, primarily caused by the toxicity of chemotherapy drugs and radiation therapy, leading to extensive damage to epithelial cells. This study aims to validate the effectiveness of "situational augmented reality-assisted instruction" in an educational intervention program for oral mucositis care in enhancing nursing personnel's knowledge of oral mucositis care, oral mucositis care abilities, clinical reasoning skills, and learning engagement. A randomized clinical trial (RCT) was conducted using convenience sampling, targeting nursing personnel from cancer-related units at a teaching hospital in northern Taiwan. A follow-up study with repeated measures in two groups was performed. Self-developed scales based on relevant literature and expert recommendations were used to assess knowledge of oral mucositis care and self-evaluated oral mucositis care abilities. Additionally, the Clinical Reasoning Scale (CRS) by Huang et al. (2023) and the Learning Engagement Scale revised by Chiu (2020) were employed as research tools. Data were analyzed using SPSS version 29.0, with descriptive statistics including frequency distribution, percentage, mean, and standard deviation. The results of this study will provide relevant institutions and educational training units with references for the content and assessment of oral mucositis care courses for cancer nursing personnel, and further applications of the research findings.

02

Conditions studied

  • Nursing Education

Browse trials for

Keywords

  • Augmented Reality
  • Oral Mucositis
03

In context

Stomatitis

306 studies on the registry are indexed under Stomatitis; 75 are open to participants now.

This study's planned enrollment of 110 is above the median of 60 across 276 interventional studies indexed under Stomatitis.

Browse Stomatitis studies →

Lead sponsor

Mackay Memorial Hospital is the lead sponsor of 118 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cancer-related nursing staff from a medical center in northern Taiwan.
  • Individuals willing to participate in this study and who have signed the form.

Exclusion criteria

Exclusion Criteria:

  • Nursing staff from non-cancer-related departments or departments not included in the eligibility criteria.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
110 participants (estimated)

Study arms

  • Experimental
    Situational Augmented Reality-Assisted Teaching

    Using situational augmented reality-assisted teaching as a case, different grades of oral mucositis are presented for learners to perform care for various stages of oral mucositis. Through clinical reasoning, learners select appropriate interventions and directly observe changes and outcomes in the patient's oral mucosa.

    Other: Situational Augmented Reality-Assisted Teaching

  • Placebo comparator
    Classroom Teaching

    Here is the translation in English: "Explain the causes and effects of oral mucositis. Explain the timing of oral mucositis assessment, assessment tools, and how to use them. Explain the different stages of oral mucositis and how to provide appropriate treatment and care for each stage. Share clinical case examples, guide learners to describe the case situations, and encourage them to understand and reflect on how to perform proper assessment and care, and provide feedback to the learners." Explain the causes and effects of oral mucositis. Describe the appropriate timing for oral mucositis assessment, introduce assessment tools, and demonstrate how to use them. Discuss the different grades of oral mucositis and how to provide proper treatment and care based on its severity. Share real-life clinical cases to guide learners in describing the scenario, understanding and reflecting on how to conduct proper assessment and care, and provide feedback to the learners.

    Other: Classroom Teaching

Interventions

  • OtherSituational Augmented Reality-Assisted Teaching

    Using situational augmented reality-assisted teaching as a case study, learners are presented with varying grades of oral mucositis. Learners then perform appropriate care for each grade of mucositis. Through clinical reasoning, they select suitable interventions, and finally, directly observe changes and outcomes in the patient's oral mucosa.

  • OtherClassroom Teaching

    Classroom Teaching and Case Sharing Introduction to Updated Oral Mucositis Guidelines and Care Management of Common Oral Mucositis Complications Case Sharing on Oral Mucositis Complication Management: Researchers

06

What researchers measure

Primary outcomes

  1. The Effects of Contextual-Based Augmented Reality Facilitated Education in Promoting Oral Mucositis Care among Nurses

    First Outcome Measures: \*\*Oral Mucositis Care Knowledge Scale\*\* This study will assess Oral Mucositis care knowledge using the \*\*Oral Mucositis Care Knowledge Scale\*\*. The scale ranges from \*\*0 to 100\*\*, with higher scores indicating \*\*better\*\* knowledge levels. The assessment will be conducted at \*\*baseline and post-intervention\*\* to measure changes in Oral Mucositis care knowledge over time. Time Frame: 2months.

    Time frame: 2 months

Secondary outcomes

  1. Clinical Reasoning Scale Description

    Time frame: The scale ranges from 16 to 80, with higher scores representing better clinical reasoning ability. Measurements will be taken before and after the intervention to assess changes in clinical reasoning performance. Time Frame: 6months.

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2025 to primary completion in Apr 2025, 2 months.

Of 65 non-industry interventional studies with no phase under Stomatitis, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 57. This study's 2 months is below that.

Counting every sponsor, half of 73 studies reached it within 14 months; a quarter within 10 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 6, 2025
First posted
Jan 8, 2026
StartActual
Feb 4, 2025
Primary completionActual
Apr 28, 2025
CompletionEst.
Dec 28, 2025
Last update
Jan 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07327333
Responsible party
Sponsor
First posted
Jan 8, 2026
Start date
Feb 4, 2025
Primary completion
Apr 28, 2025
Completion
Dec 28, 2025 (estimated)
Last update
Jan 8, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion